Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

142 CO-TRIMOXAZOLE
Angioedema
(2006): Ruscin JM+, Am J Geriatr Pharmacother 4(4), 325
(1988): Fihn SD+, AnnInternMed108, 350 (1–5%)
Bullous dermatitis
(1995): Roholt NS+, JAmAcadDermatol32(2 Pt 2), 367
(1989): Caumes E+, Presse Med (French) 18, 1708
Dermatitis
(1989): Atahan IL+, Br J Radiol 62, 1107 (at previously irradiated
area)
(1987): Vukelja SJ+, Cancer Treat Rep 71, 668 (at previously
irradiated area)
(1984): Shelley WB+, JAmAcadDermatol11, 53 (at site of
previous sunburn)
Erythema multiforme
(1999): Lehman DF+, J Clin Pharmacol 39, 533
(1998): Siegfried EC+, JAmAcadDermatol39, 797 (passim)
(1997): Rieder MJ+, Pediatr Infect Dis J 16, 1028 (70% in
children with HIV)
(1995): Jick H+, Pharmacotherapy 15, 428
(1991): Tilden ME+, Arch Ophthalmol 109, 67
(1990): Chan HL+, Arch Dermatol 126, 43
(1989): Alanko K+, Acta Derm Venereol (Stockh) 69, 223
(1988): Hira SK+, JAmAcadDermatol19, 451
(1988): Platt R+, JInfectDis158, 474
(1987): Penmetcha M, BMJ 295, 556
(1987): Schöpf E, Infection 15 (Suppl 5P), S254
(1985): Heer M+, Gastroenterology 88, 1954
(1982): Brettle RP+, JInfect4, 149
Erythema nodosum
Erythroderma
Exanthems
(2006): Eastern JS, NJ (from Internet) (observation)
(2005): Beer AM+, Forsch Komplementarmed Klass Naturheilkd
12(1), 32
(1999): Iborra C+, Arch Dermatol 135, 350
(1998): Blumenthal HL, Beachwood, OH (personal case)
(observation)
(1998): Hattori N+, JDermatol25, 269
(1998): Litt JZ, Beachwood, OH (personal case) (observation)
(1997): Blumenthal HL, Beachwood, OH (personal case)
(observation)
(1997): Palau LA+, Infect Med 14, 846
(1996): Caumes E, Rev Mal Respir (French) 13, 101 (passim)
(1995): Hertl M+, Br J Dermatol 132, 215
(1995): Wolkenstein P+, Arch Dermatol 131, 544
(1994): Litt JZ, Beachwood, OH (personal case) (observation)
(1993): Agarwal BR+, Indian Pediatr 30, 1026
(1993): Litt JZ, Beachwood, OH (personal case) (observation)
(1993): Malnick SDH+, Ann Pharmacotherapy 27, 1139
(1990): Medina I+, NEnglJMed323, 776 (47% in AIDS)
(1988): DeRaeve L+, Br J Dermatol 119, 521
(1988): Fihn SD+, AnnInternMed108, 350 (1–5%)
(1988): Sattler FR+, AnnInternMed109, 280 (44% in AIDS)
(1988): Weinke T+, Dtsch Med Wochenschr (German) 113, 1129
(25% in AIDS)
(1987): Goa KL+, Drugs 33, 242 (65% in AIDS)
(1987): Schöpf E, Infection 15 (Suppl 5P), S254
(1986): Sonntag MR+, Schweiz Med Wochenschr (German)
116, 142
(1985): DeHovitz JA+, AnnInternMed103, 479
(1985): Maayan S+, Arch Intern Med 145, 1607
(1984): Gordon FM+, AnnInternMed100, 495 (51% in AIDS)
(1984): Kovacs JA+, AnnInternMed100, 663 (29% in AIDS)
(1983): Mitsuyasu R+, NEnglJMed308, 1535 (69% in AIDS)
(1982): Goetz MB+, JAMA 247, 3118
(1980): Fennell RS+, Clin Pediatr 19, 124
Exfoliative dermatitis
(1990): Ponte CD+, Drug Intell Clin Pharm 24, 140 (feet)
Fixed eruption
(2006): Nnoruka EN+, Int J Dermatol 45(9), 1062
(2006): Rasi A+, Dermatol Online J 12(6), 12 (non-pigmenting)
(2006): Ruscin JM+, Am J Geriatr Pharmacother 4(4), 325
(2004): Ozkaya-Bayazit E, JAmAcadDermatol51(2 Suppl), S102
(2004): Zawar V+, IntJSTDAIDS15(8), 560 (3 cases)
(2002): Litt JZ, Beachwood, OH (glans penis) (recurrent)
(personal case)
(2001): Bayazit-Ozkaya E+, JAmAcadDermatol45(5), 712
(2000): Ozkaya-Bayazit E+, Eur J Dermatol 10, 288
(1999): Mohamed KB, JPediatr135, 396
(1999): Morelli JG+, JPediatr134, 365
(1999): Ozkaya-Bayazit E+, Contact Dermatitis 41(4), 185 (27
cases)
(1998): Lee AY, Contact Dermatitis 38(5), 258
(1998): Mahboob A+, Int J Dermatol 37, 833
(1998): Ozkaya-Bayazit E+, Contact Dermatitis 39, 87
(trimethoprim)
(1997): Gruber F+, Clin Exp Dermatol 22, 144
(1997): Ozkaya-Bayazit E+, Br J Dermatol 137, 1028 (linear)
(trimethoprim)
(1996): Sharma VK+, JDermatol23, 530
(1995): Wolkenstein P+, Arch Dermatol 131, 544
(1993): Oleaga JM+, Contact Dermatitis 29, 155
(1993): Ramam M+, Indian Pediatr 30, 110 (in an infant)
(1992): Arifhodzic F+, Vojnosanit Pregl 49(1), 30
(1992): Lim JT+, Ann Acad Med Singapore 21, 408
(1991): Jain VK+, Ann Dent 50, 9 (oral mucous membrane)
(1991): Smoller BR+, JCutanPathol18, 13
(1991): Thankappen TP+, Int J Dermatol 30, 867 (36.3%)
(1990): Gaffoor PMA+, Cutis 45, 242 (genitalia)
(1989): Basomba A+, J Allergy Clin Immunol 84, 409
(1989): Bharija SC+, Australas J Dermatol 30, 43
(1989): Gupta R, Indian J Dermatol 55, 181 (in an infant)
(1989): Varsano I+, Dermatologica 178, 232
(1988): Baird BJ+, Int J Dermatol 27, 170 (bullous and
generalized)
(1988): Bharija SC+, Dermatologica 176, 108 (in an infant)
(1987): Amir J+, Drug Intell Clin Pharm 21, 41
(1987): Hughes BR+, Br J Dermatol 116, 241
(1987): Van Voorhees A+, Am J Dermatopathol 9, 528
(1986): Kanwar AJ+, Dermatologica 172, 230
(1985): Gomez B+, Allergol Immunopathol Madr (Spanish) 13, 87
(1984): Pandhi RK+, Sex Transm Dis 11, 164
(1982): Gibson JR, BMJ 284, 1529
(1980): Talbot MD, Practitioner 224, 823
Hand–foot syndrome
(1999): van Rooijen MM+, Hautarzt 50(4), 280
Jarisch–Herxheimer reaction
(2001): Peschard S+, Presse Med 30(31), 1549
Lichenoid eruption
(1994): Berger TG+, Arch Dermatol 130, 609
Linear IgA dermatosis
(2002): Cohen LM+, JAmAcadDermatol46, S32 (passim)
(1997): Paul C+, Br J Dermatol 136, 406
(1994): Kuechle MK+, JAmAcadDermatol30, 187
Lupus erythematosus
(1985): Stratton MA, Clin Pharm 4, 657
Photo-recall
(1990): Leslie MD+, Br J Radiol 63, 661
(1987): Vukelja SJ+, Cancer Treat Rep 71, 668 (at previously
irradiated area)
(1984): Shelley WB+, JAmAcadDermatol11, 53 (at site of
previous sunburn)
Photosensitivity
(1994): Berger TG+, Arch Dermatol 130, 609 (in HIV-infected) (4
cases)
(1994): Shelley WB+, Cutis 53, 162 (observation)
(1987): Schöpf E, Infection 15 (Suppl 5P), S254
(1986): Chandler MJ, JInfectDis153, 1001
Pruritus
(1997): Caumes E+, Arch Dermatol 133, 465